Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
<strong>Background </strong>Around one million individuals in the UK have heart failure (HF), a chronic disease that causes significant morbidity and mortality. N-terminal pro–B-type natriuretic peptide (NT-proBNP) monitoring could help improve the care of patients with HF in the communi...
Үндсэн зохиолчид: | Chami, J, Fleming, S, Taylor, C, Bankhead, C, James, T, Shine, B, McLellan, J, Hobbs, FDR, Perera, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Royal College of General Practitioners
2022
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
-н: Jason Chami, зэрэг
Хэвлэсэн: (2022-09-01) -
The integration of BNP and NT-proBNP into clinical medicine
-н: Swiss Medical Weekly
Хэвлэсэн: (2007-01-01) -
Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
-н: Hussein Alawieh, зэрэг
Хэвлэсэн: (2019-11-01) -
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
-н: Robert A. Lewis, зэрэг
Хэвлэсэн: (2020-05-01) -
A Point-of-Care Measurement of NT-proBNP for Heart Failure Patients
-н: Cesar Navarro, зэрэг
Хэвлэсэн: (2020-01-01)